March 30, 2026 · Form 4 insider transaction
EDGEMOND JAMES sold 200 shares of United Therapeutics Corporation at $598.83 per share, a transaction worth $119.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.; This transaction was executed in multiple trades at prices ranging from $598.50 to $599.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.